Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth J Zost

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Cell Reports|August 19, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Iscience|December 13, 2021
Standardized two-step testing of antibody activity in COVID-19 convalescent plasmaPavlo Gilchuk, Isaac Thomsen, Sandra Yoder, et al.
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Nature Microbiology|September 25, 2023
Host range, transmissibility and antigenicity of a pangolin coronavirusYixuan J Hou, Shiho Chiba, Sarah R Leist, et al.
Nature Microbiology|March 13, 2026
Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variantsSeth J Zost, Naveenchandra Suryadevara, Lauren E Williamson, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature Microbiology|September 22, 2021
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktailJinhui Dong, Seth J Zost, Allison J Greaney, et al.
Nature Medicine|March 5, 2021
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesRita E Chen, Xianwen Zhang, James Brett Case, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cell Reports|August 19, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Iscience|December 13, 2021
Standardized two-step testing of antibody activity in COVID-19 convalescent plasmaPavlo Gilchuk, Isaac Thomsen, Sandra Yoder, et al.
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Nature Microbiology|September 25, 2023
Host range, transmissibility and antigenicity of a pangolin coronavirusYixuan J Hou, Shiho Chiba, Sarah R Leist, et al.
Nature Microbiology|March 13, 2026
Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variantsSeth J Zost, Naveenchandra Suryadevara, Lauren E Williamson, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature Microbiology|September 22, 2021
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktailJinhui Dong, Seth J Zost, Allison J Greaney, et al.
Nature Medicine|March 5, 2021
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesRita E Chen, Xianwen Zhang, James Brett Case, et al.
Pageof 5